Skip to main content
Equibles
PLSE logo

PLSE · Pulse Biosciences, Inc. · Webcasts, Transcripts & Audio

Track PLSE — free

Use PLSE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PLSE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$49.75 +1.85 (+3.86%)
Russell 2000 member Rebalance outlook locked
Market Cap
$3.68B
Shares
71.32M
Volume · Oct 5 193.45K Avg daily vol (3M) 497.63K

Pulse Biosciences, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Pulse Biosciences, Inc. (PLSE), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $265,000 −$14.00M '22 Q2 22-08-10 ▼100% $ −$18.04M '22 Q3 22-11-10 · $ −$9.20M '22 Q4 23-03-30 ▼100% $ −$9.80M '23 Q1 23-05-11 ▼100% $ −$9.91M '23 Q2 23-08-10 · $ −$10.57M '23 Q3 23-11-13 · $ −$11.93M '23 Q4 24-03-28 · $ −$10.14M '24 Q1 24-05-07 · $ −$12.68M '24 Q3 24-10-30 · $ −$19.39M '24 Q4 25-03-28 · $ −$16.80M '25 Q1 25-05-08 · $ −$19.17M '25 Q2 25-08-12 · $86,000 −$19.39M '25 Q3 25-11-05 · $264,000 −$17.43M '25 Q4 26-02-19 · $401,000 −$18.58M '26 Q1 26-05-07 LATEST · $434,000 −$24.66M '26 Q2 26-08-06
Conference
Investor event
2026-08-11
Pulse Biosciences, Inc. (PLSE) August 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-06
Pulse Biosciences, Inc. (PLSE) Q2 2026 Earnings Call Transcript
Confident tone NSPFA cardiac catheter program Pivotal IDE study enrollment Balance sheet and financing
Revenue
$434,000
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-10
Pulse Biosciences, Inc. (PLSE) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-07
Pulse Biosciences, Inc. (PLSE) Q1 2026 Earnings Call Transcript
Confident tone U.S. pivotal IDE study enrollment nsPFA technology platform nPulse Cardiac Catheter for atrial fibrillation
Revenue
$401,000
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-04-16
Pulse Biosciences, Inc. (PLSE) April 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-03-18
Pulse Biosciences, Inc. (PLSE) March 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-03-04
Pulse Biosciences, Inc. (PLSE) March 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-02-19
Pulse Biosciences, Inc. (PLSE) Q4 2025 Earnings Call Transcript
Confident tone N-Pulse cardiac catheter / electrophysiology AF program Reimbursement and regulatory labeling timing Balance sheet and funding strategy
Revenue
$264,000*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-05
Pulse Biosciences, Inc. (PLSE) Q3 2025 Earnings Call Transcript
Confident tone Clinical / regulatory progress Cardiac surgery (NANOCLAMP) Soft tissue / thyroid ablation (Vybrance)
Revenue
$86,000
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
Pulse Biosciences, Inc. (PLSE) Q2 2025 Earnings Call Transcript
Confident tone nsPFA 360 catheter for atrial fibrillation nsPFA technology platform Regulatory pathway and timing
Revenue
$
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Pulse Biosciences, Inc. (PLSE) Q1 2025 Earnings Call Transcript
Confident tone nsPFA Technology Platform Regulatory Milestones Soft Tissue / Thyroid Ablation Commercialization
Revenue
$
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-28
Pulse Biosciences, Inc. (PLSE) Q4 2024 Earnings Call Transcript
Confident tone Nanosecond PFA technology platform Atrial fibrillation / cardiac surgery programs Financial performance and balance sheet
Revenue
$*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-30
Pulse Biosciences, Inc. (PLSE) Q3 2024 Earnings Call Transcript
Confident tone Soft Tissue Ablation (thyroid nodules) Regulatory pathway and approvals Nano-PFA Cardiac Surgical System for AF
Revenue
$
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Pulse Biosciences, Inc. (PLSE) Q1 2024 Earnings Call Transcript
Positive tone nsPFA technology platform Financial results and operating expenses Rights offering / capital raise
Revenue
$
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-28
Pulse Biosciences, Inc. (PLSE) Q4 2023 Earnings Call Transcript
Confident tone CellFX nsPFA percutaneous electrode Key opinion leader engagement and mapping integration CellFX nsPFA surgical clamp
Revenue
$*
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-13
Pulse Biosciences, Inc. (PLSE) Q3 2023 Earnings Call Transcript
Revenue
$
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
Pulse Biosciences, Inc. (PLSE) Q2 2023 Earnings Call Transcript
Revenue
$
▼ 100% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-11
Pulse Biosciences, Inc. (PLSE) Q1 2023 Earnings Call Transcript
Revenue
$
▼ 100% YoY
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-30
Pulse Biosciences, Inc. (PLSE) Q4 2022 Earnings Call Transcript
Revenue
$*
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-10
Pulse Biosciences, Inc. (PLSE) Q3 2022 Earnings Call Transcript
Revenue
$
▼ 100% YoY
Diluted EPS
$-0.49
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-10
Pulse Biosciences, Inc. (PLSE) Q2 2022 Earnings Call Transcript
Revenue
$265,000
Diluted EPS
$-0.44
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-11
Pulse Biosciences, Inc. (PLSE) Q1 2022 Earnings Call Transcript
Revenue
$444,000
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-01-11
Pulse Biosciences, Inc. (PLSE) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-15
Pulse Biosciences, Inc. (PLSE) Q3 2021 Earnings Call Transcript
Revenue
$574,000
Diluted EPS
$-0.48
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-09
Pulse Biosciences, Inc. (PLSE) Q2 2021 Earnings Call Transcript
Diluted EPS
$-0.58
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-10
Pulse Biosciences, Inc. (PLSE) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-22
Pulse Biosciences, Inc. (PLSE) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-09
Pulse Biosciences, Inc. (PLSE) Q3 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-10
Pulse Biosciences, Inc. (PLSE) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-11
Pulse Biosciences, Inc. (PLSE) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–30 of 30 webcasts
Key facts CIK 1625101 CUSIP 74587B101 13F (30d) 1 filings 1 filers Visit website Investor relations